Hydrophobicity identifies false positives and false negatives in peptide-MHC binding.

MHC class I hydrophobicity machine learning neural networks peptide

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 02 09 2022
accepted: 17 10 2022
entrez: 24 11 2022
pubmed: 25 11 2022
medline: 25 11 2022
Statut: epublish

Résumé

Major Histocompability Complex (MHC) Class I molecules allow cells to present foreign and endogenous peptides to T-Cells so that cells infected by pathogens can be identified and killed. Neural networks tools such as NetMHC-4.0 and NetMHCpan-4.1 are used to predict whether peptides will bind to variants of MHC molecules. These tools are trained on data gathered from binding affinity and eluted ligand experiments. However, these tools do not track hydrophobicity, a significant biochemical factor relevant to peptide binding, in their predictions. A previous study had concluded that the peptides predicted to bind to HLA-A*0201 by NetMHC-4.0 were much more hydrophobic than expected. This paper expands that study by also focusing on HLA-B*2705 and HLA-B*0801, which prefer binding hydrophilic and balanced peptides respectively. The correlation of hydrophobicity of 9-mer peptides with their predicted binding strengths to these various HLAs was investigated. Two studies were performed, one using the data that the two neural networks were trained on, and the other using a sample of the human proteome. NetMHC-4.0 was found to have a statistically significant bias towards predicting highly hydrophobic peptides as strong binders to HLA-A*0201 and HLA-B*2705 in both studies. Machine Learning metrics were used to identify the causes for this bias: hydrophobic false positives and hydrophilic false negatives. These results suggest that the retraining the neural networks with biochemical attributes such as hydrophobicity and better training data could increase the accuracy of their predictions. This would increase their impact in applications such as vaccine design and neoantigen identification.

Identifiants

pubmed: 36419888
doi: 10.3389/fonc.2022.1034810
pmc: PMC9677119
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1034810

Informations de copyright

Copyright © 2022 Solanki, Riedel, Cornette, Udell and Vasmatzis.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Cell. 2017 Nov 30;171(6):1259-1271.e11
pubmed: 29107330
J Pept Sci. 1995 Sep-Oct;1(5):319-29
pubmed: 9223011
Brief Bioinform. 2020 Jul 15;21(4):1119-1135
pubmed: 31204427
J Mol Biol. 1982 May 5;157(1):105-32
pubmed: 7108955
Proc Natl Acad Sci U S A. 2011 Jun 21;108(25):10174-7
pubmed: 21606332
Mol Immunol. 1996 Nov;33(16):1231-9
pubmed: 9129159
Nature. 2017 Nov 23;551(7681):517-520
pubmed: 29132144
Mol Immunol. 1983 Apr;20(4):483-9
pubmed: 6191210
PLoS Comput Biol. 2017 Aug 23;13(8):e1005725
pubmed: 28832583
J Mol Biol. 1987 Jun 5;195(3):659-85
pubmed: 3656427
PLoS One. 2014 Jul 02;9(7):e97282
pubmed: 24988075
Cell. 2020 Jun 25;181(7):1489-1501.e15
pubmed: 32473127
Nat Rev Immunol. 2011 Nov 11;11(12):823-36
pubmed: 22076556
Nucleic Acids Res. 2020 Jul 2;48(W1):W449-W454
pubmed: 32406916
Nature. 1991 Sep 26;353(6342):326-9
pubmed: 1922338
Bioinformatics. 2016 Feb 15;32(4):511-7
pubmed: 26515819
Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515
pubmed: 30395287
Mol Cell Proteomics. 2019 Dec;18(12):2459-2477
pubmed: 31578220
J Mol Biol. 1997 Apr 4;267(3):707-26
pubmed: 9126848
J Comput Aided Mol Des. 2002 Aug-Sep;16(8-9):535-44
pubmed: 12602948
Proc Natl Acad Sci U S A. 2015 Apr 7;112(14):E1754-62
pubmed: 25831525

Auteurs

Arnav Solanki (A)

Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN, United States.

Marc Riedel (M)

Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN, United States.

James Cornette (J)

Department of Mathematics, Iowa State University, Ames, IA, United States.

Julia Udell (J)

Department of Electrical and Computer Engineering, University of Minnesota, Minneapolis, MN, United States.
Biomarker Discovery Group, Mayo Clinic, Center for Individualized Medicine, Rochester, MN, United States.

George Vasmatzis (G)

Biomarker Discovery Group, Mayo Clinic, Center for Individualized Medicine, Rochester, MN, United States.

Classifications MeSH